Michel JanicotChief Development Officer at InteRNA Technologies
Michel holds a Ph.D. degree in Biochemistry (Molecular and Cellular Biology) from University Paris VII (France) and was Postdoctoral Fellow at The Johns Hopkins University (Baltimore, MD. USA). He has over 35 years of professional experience in Oncology preclinical and early clinical pharmaceutical drug development in increasing leadership roles at Rhone-Poulenc Rorer (Sanofi) and Janssen (Johnson & Johnson). Michel has a long-lasting hands-on experience and strategic expertise and multidisciplinary network in the discovery and development of RNA-based therapeutics (mRNAs, miRNA/siRNAs, and ASOs) with strategic focus in oncology therapeutic intervention.